Dolutegravir and weight gain: an unexpected bothering side effect?
Year: 2017
Type: article
Study design: Observational Study
Source: AIDS
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: weight gain, body mass index, HIV infection, antiretroviral therapy, abacavir/lamivudine, tenofovir/emtricitabine, drug-induced weight gain, obesity, sex differences, adverse drug reactions, antiretroviral therapy discontinuation, real-world cohort, antiretroviral drug safety, HIV-associated lipodystrophy
Open Access status: closed
OpenAlex ID: W2621358721
